Repositioning Candidate Details
Candidate ID: | R0573 |
Source ID: | DB03010 |
Source Type: | experimental; investigational |
Compound Type: | small molecule |
Compound Name: | Patupilone |
Synonyms: | (−)-epothilone B; Epo B; Epothilone B; Patupilone |
Molecular Formula: | C27H41NO6S |
SMILES: | [H]\C(=C(\C)[C@]1([H])C[C@]2([H])O[C@]2(C)CCC[C@]([H])(C)[C@]([H])(O)[C@@]([H])(C)C(=O)C(C)(C)[C@@]([H])(O)CC(=O)O1)C1=CSC(C)=N1 |
Structure: |
|
DrugBank Description: | Epothilone B is a 16-membered macrolide that mimics the biological effects of taxol. |
CAS Number: | 152044-54-7 |
Molecular Weight: | 507.683 |
DrugBank Indication: | Investigated for use/treatment in ovarian cancer, lung cancer, brain cancer, breast cancer, and gastric cancer. |
DrugBank Pharmacology: | -- |
DrugBank MoA: | The principal mechanism of the epothilone class is inhibition of microtubule function. Microtubules are essential to cell division, and epothilones therefore stop cells from properly dividing. Epothilone B possess the same biological effects as taxol both in vitro and in cultured cells. This is because they share the same binding site, as well as binding affinity to the microtubule. Like taxol, epothilone B binds to the αβ-tubulin heterodimer subunit. Once bound, the rate of αβ-tubulin dissociation decreases, thus stabilizing the microtubules. Furthermore, epothilone B has also been shown to induce tubulin polymerization into microtubules without the presence of GTP. This is caused by formation of microtubule bundles throughout the cytoplasm. Finally, epothilone B also causes cell cycle arrest at the G2-M transition phase, thus leading to cytotoxicity and eventually cell apoptosis. |
Targets: | Tubulin alpha-3C/D chain; Tubulin beta chain; Tubulin beta-1 chain; Tubulin beta-4B chain; Tubulin beta-4A chain; Tubulin alpha-4A chain; Tubulin beta-3 chain; Tubulin alpha-1C chain; Tubulin alpha-8 chain; Tubulin alpha-1B chain; Tubulin alpha-1A chain |
Inclusion Criteria: | Therapeutic strategy associated |